Mitophagy — selective autophagy of damaged mitochondria — distinct from general macroautophagy (autophagy lc3 axis). Quality-control mechanism preventing accumulation of dysfunctional mitochondria. Canonical PINK1/Parkin pathway: (1) Healthy mitochondria — PINK1 (PTEN-induced kinase 1) is imported through TOM/TIM complexes to the inner membrane → MPP-cleaved → degraded. PINK1 levels stay low. (2) Damaged mitochondria — loss of inner-membrane potential (Δψm) blocks PINK1 import → PINK1 accumulates on the outer membrane (OMM) → activates by trans-autophosphorylation → phosphorylates ubiquitin Ser65 + Parkin. (3) Parkin recruitment + amplification — pSer65-Ub binds + activates Parkin (an E3 ubiquitin ligase) → Parkin polyubiquitinates OMM proteins (Mfn1/2, MIRO1/2, TOM20) → more pSer65-Ub → feed-forward loop. (4) Autophagy receptors — OPTN, NDP52, TAX1BP1, p62 bind polyubiquitin chains → LC3 recruitment → autophagosome enclosure → lysosomal fusion → degradation. PINK1/Parkin-independent mitophagy: BNIP3, NIX, FUNDC1 are receptors that bind LC3 directly (no ubiquitin step) — important for developmental mitophagy (erythrocyte maturation, hypoxia response). Disease relevance: PINK1 + PRKN (Parkin) loss-of-function mutations → autosomal recessive early-onset Parkinson disease (cross-link parkinson alpha synuclein aggregation — failure of dopaminergic mitochondrial QC). Therapeutic landscape: urolithin A (a gut-microbiome metabolite of ellagic acid) is the first compound demonstrated to induce mitophagy in humans (MIBIOTECH trial); rapamycin + metformin enhance mitophagy via AMPK + mTORC1; NAD precursors (NMN, NR) support PARP/SIRT axis. Cross-links: autophagy lc3 axis (parent autophagy mechanism), parkinson alpha synuclein aggregation (PINK1/PRKN loss → familial PD), ampk signaling (mitophagy induction via energy stress), mtor signaling (mTORC1 inhibition promotes mitophagy).
Organ Systems
nervous
musculoskeletal
cardiovascular
Pathway Steps
healthy mitochondrion (intact Δψm) → PINK1 imported + degraded by MPP — via low steady-state PINK1; no Parkin recruitment. PINK1 is constantly made and constantly destroyed on healthy mitochondria: imported across the intact membrane potential (Δψm), cleaved by the matrix protease MPP and then PARL, and retro-translocated for proteasomal degradation. This futile import-and-destroy cycle keeps PINK1 near zero — a built-in timer that reports membrane health.
damaged mitochondrion (Δψm loss) → PINK1 accumulation on outer membrane — via loss of inner-membrane import → OMM retention; trans-autophosphorylation. When a mitochondrion is damaged and loses Δψm, PINK1 can no longer be imported and cleaved, so it stabilizes and accumulates on the outer membrane (OMM). This conditional stabilization is the core sensing step — converting loss of membrane potential into a localized “eat me” signal only on defective organelles.
PINK1 active (OMM) → Ub-Ser65 phosphorylation + Parkin activation — via pSer65-Ub binds + activates Parkin E3 ligase. Stabilized PINK1 phosphorylates ubiquitin at Ser65 and the Parkin Ubl domain, recruiting and switching on the E3 ligase Parkin. Phospho-ubiquitin and Parkin form a feed-forward loop that amplifies the ubiquitin signal on the damaged organelle. Loss-of-function mutations in PINK1 or Parkin cause autosomal-recessive Parkinson’s disease.
Parkin E3 ligase → OMM protein polyubiquitination (Mfn1/2, MIRO, TOM20) — via feed-forward — more pSer65-Ub → more Parkin recruitment + activation. Activated Parkin polyubiquitinates many OMM proteins (Mfn1/2, MIRO, TOM20). Tagging mitofusins blocks fusion to isolate the damaged unit, and MIRO loss halts its transport — quarantining the organelle before disposal. The dense ubiquitin coat is the platform that autophagy receptors then read.
polyubiquitinated mitochondrion → OPTN / NDP52 / TAX1BP1 / p62 binding → LC3 recruitment — via autophagy receptors bridge Ub chains to LC3-decorated autophagosome. Autophagy receptors (OPTN, NDP52, TAX1BP1, p62) bind the poly-Ub coat and simultaneously bind LC3 via LIR motifs, tethering the mitochondrion to the forming autophagosome. TBK1 phosphorylates these receptors to strengthen binding — linking the same kinase used in innate immunity to organelle clearance.
mitochondrion in autophagosome → lysosomal degradation — via STX17-mediated autophagosome-lysosome fusion → mitochondrial content recycled. The engulfed mitochondrion is delivered to the lysosome, where acid hydrolases degrade it and recycle its components. This completes mitochondrial quality control; failure to clear damaged mitochondria leaves a source of ROS and pro-apoptotic factors, contributing to neurodegeneration and aging.
developmental mitophagy (no Ub step) → BNIP3 / NIX / FUNDC1 → direct LC3 binding — via erythrocyte maturation + hypoxia response — Parkin-independent route. A ubiquitin-independent route also exists: receptor-mediated mitophagy uses the OMM proteins BNIP3, NIX (BNIP3L), and FUNDC1, which bind LC3 directly via their own LIR motifs. This drives programmed mitochondrial clearance during development — e.g. NIX in red-blood-cell maturation — and responds to hypoxia.
urolithin a (activator) — direct mitophagy induction (ellagic-acid-derived gut metabolite). MIBIOTECH human trial: improved mitochondrial gene expression + muscle endurance